SAB Biotherapeutics Inc. (SABS) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
2.28
0.02 (0.88%)
At close: Sep 05, 2025, 3:59 PM
2.19
-3.91%
After-hours: Sep 05, 2025, 06:11 PM EDT

SAB Biotherapeutics Revenue

SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.96% growth. For the quarter ending June 30, 2025, SAB Biotherapeutics generated $0 in revenue.
Revenue (ttm)
1.32M
Revenue Growth
-40.96%
Price / Sales Ratio
26.55
Revenue / Employee
20.98K
Employees
63
Market Cap
23.74M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 1.32M -40.96%
Dec 31, 2023 2.24M -90.63%
Dec 31, 2022 23.9M -60.73%
Dec 31, 2021 60.88M +10.21%
Dec 31, 2020 55.24M +1504.82%
Dec 31, 2019 3.44M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.